Amgen, AstraZeneca strike drug development deal
Amgen has entered a development deal with London-based AstraZeneca to jointly commercialize five anti-inflammation drugs. Under the terms of the agreement announced April 2, AstraZeneca will pay a one-time $50 million payment to Amgen and will be responsible for helping the Thousand Oaks-based biotech giant commercialize its inflammation drug pipeline. The firms said in a Read More →
Read More →Ojai Community Bank out from regulatory order
Ojai Community Bank is out from under a regulatory consent order imposed on it last year and reported a profitable 2011, swinging back from a loss the year earlier. The small Ojai-based bank said March 27 that regulators had lifted a Federal Deposit Insurance Corp. order placed on it on March 31, 2011. The announcement Read More →
Read More →Guest op/ed: The business world needs women to help us get out of this mess
Traditional male-centric business practices as well as unregulated policies imposed on our modern society got us into this global recession.
Read More →Letter: With Prop. 29, the devil is in the details
This measure allows Californians’ hard-earned tax dollars to be spent outside the state, even outside the country.
Read More →U.S. cracks down on Chinese solar
Handing a victory to SolarWorld Industries, which maintains offices in Camarillo, the U.S. Department of Commerce has issued a preliminary ruling that would impose a series of small tariffs on solar panels imported from China. According to a press release from a coalition of panel makers that supported the SolarWorld dumping case, the March 20 Read More →
Read More →